RxNorm Semantic Concepts Index - 133
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "133".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 133001 | Neomycin palmitate | Designated preferred name (PT) | NO | |
| RxCUI: 133001 | Neomycin palmitate | Full form of descriptor (FN) | NO | |
| RxCUI: 133002 | Neomycin undecenoate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133002 | Neomycin undecenoate | Designated preferred name (PT) | NO | |
| RxCUI: 133002 | Neomycin undecenoate | Full form of descriptor (FN) | NO | |
| RxCUI: 133003 | Apramycin sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 133003 | Apramycin sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 133003 | Apramycin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 133008 | Amoxicillin trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 133008 | Amoxicillin trihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 133008 | Amoxicillin trihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1330085 | beef liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330087 | Hedera helix flowering twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330088 | Spongilla lacustris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330089 | Okoubaka aubrevillei bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330090 | Scrophularia nodosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1330091 | Sedum acre extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330092 | Cimex lectularius preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330093 | Packera aurea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1330093 | Packera aurea whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133010 | Ormetoprin | Designated preferred name (PT) | NO | |
| RxCUI: 133010 | Ormetoprin | Full form of descriptor (FN) | NO | |
| RxCUI: 133011 | Sulfabromomethazine sodium | Designated preferred name (PT) | NO | |
| RxCUI: 133011 | Sulfabromomethazine sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 133011 | Sulfabromomethazine sodium | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 133013 | Ipronidazole hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133013 | Ipronidazole hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133015 | Imidocarb dihydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133015 | Imidocarb dihydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133016 | Piperazine tartrate | Designated preferred name (PT) | NO | |
| RxCUI: 133016 | Piperazine tartrate | Full form of descriptor (FN) | NO | |
| RxCUI: 133018 | Levamisole resinate | Designated preferred name (PT) | NO | |
| RxCUI: 133018 | Levamisole resinate | Full form of descriptor (FN) | NO | |
| RxCUI: 133021 | Disophenol sodium | Designated preferred name (PT) | NO | |
| RxCUI: 133021 | Disophenol sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 133022 | Thenium closilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133022 | Thenium closilate | Designated preferred name (PT) | NO | |
| RxCUI: 133022 | Thenium closilate | Full form of descriptor (FN) | NO | |
| RxCUI: 133023 | Ftalofyne | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133023 | Ftalofyne | Designated preferred name (PT) | NO | |
| RxCUI: 133023 | Ftalofyne | Full form of descriptor (FN) | NO | |
| RxCUI: 133024 | Styrylpyridinium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 133024 | Styrylpyridinium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133025 | Buquinolate | Designated preferred name (PT) | NO | |
| RxCUI: 133025 | Buquinolate | Full form of descriptor (FN) | NO | |
| RxCUI: 133026 | Moenomycin A | Designated preferred name (PT) | NO | |
| RxCUI: 133026 | Moenomycin A | Full form of descriptor (FN) | NO | |
| RxCUI: 133027 | Moenomycin B>1< | Designated preferred name (PT) | NO | |
| RxCUI: 133027 | Moenomycin B>1< | Full form of descriptor (FN) | NO | |
| RxCUI: 133028 | Moenomycin B>2< | Designated preferred name (PT) | NO | |
| RxCUI: 133028 | Moenomycin B>2< | Full form of descriptor (FN) | NO | |
| RxCUI: 1330284 | Aconitum napellus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 133029 | Moenomycin C | Designated preferred name (PT) | NO | |
| RxCUI: 133029 | Moenomycin C | Full form of descriptor (FN) | NO | |
| RxCUI: 133035 | Etorphine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133035 | Etorphine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133036 | Nalorphine dinicotinate | Designated preferred name (PT) | NO | |
| RxCUI: 133036 | Nalorphine dinicotinate | Full form of descriptor (FN) | NO | |
| RxCUI: 133037 | Thialbarbital | Designated preferred name (PT) | NO | |
| RxCUI: 133037 | Thialbarbital | Full form of descriptor (FN) | NO | |
| RxCUI: 133038 | Metoserpate hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133038 | Metoserpate hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133039 | Caramiphen hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133039 | Caramiphen hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133040 | Adrenaline acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133040 | Adrenaline acetate | Designated preferred name (PT) | NO | |
| RxCUI: 133040 | Adrenaline acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 133041 | Yohimbine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 133041 | Yohimbine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 133041 | Yohimbine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 133043 | Diperodon hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 133043 | Diperodon hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 133043 | Diperodon hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133044 | Butacaine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 133044 | Butacaine sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 133044 | Butacaine sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 133044 | Butacaine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 133045 | Copper supplement | Designated preferred name (PT) | NO | |
| RxCUI: 133045 | Copper supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 133047 | Selenium supplement | Designated preferred name (PT) | NO | |
| RxCUI: 133047 | Selenium supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 133048 | Bone resorption inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 133048 | Bone resorption inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 133048 | Bone resorption inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 133048 | Bone resorption inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 133049 | Substance with angiotensin II receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 133049 | Substance with angiotensin II receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 133049 | Substance with angiotensin II receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 133049 | Substance with angiotensin II receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133049 | Substance with angiotensin II receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 133050 | Attapulgite activated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 133050 | Attapulgite activated | Designated preferred name (PT) | NO | |
| RxCUI: 133050 | Attapulgite activated | Full form of descriptor (FN) | NO | |
| RxCUI: 133050 | Attapulgite activated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133052 | Aminopromazine fumarate | Designated preferred name (PT) | NO | |
| RxCUI: 133052 | Aminopromazine fumarate | Full form of descriptor (FN) | NO | |
| RxCUI: 133053 | Caramiphen ethanedisulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 133053 | Caramiphen ethanedisulfonate | Designated preferred name (PT) | NO | |
| RxCUI: 133053 | Caramiphen ethanedisulfonate | Full form of descriptor (FN) | NO | |
| RxCUI: 133053 | Caramiphen ethanedisulfonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133053 | Caramiphen ethanedisulfonate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 133054 | Chlorhexidine diacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 133054 | Chlorhexidine diacetate | Designated preferred name (PT) | NO | |
| RxCUI: 133054 | Chlorhexidine diacetate | Full form of descriptor (FN) | NO | |
| RxCUI: 133055 | Triclobisonium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 133055 | Triclobisonium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 133056 | Chlortetracycline calcium complex | Designated preferred name (PT) | NO | |
| RxCUI: 133056 | Chlortetracycline calcium complex | Full form of descriptor (FN) | NO | |
| RxCUI: 133059 | Ceruminolytic agent | Designated preferred name (PT) | NO | |
| RxCUI: 133059 | Ceruminolytic agent | Full form of descriptor (FN) | NO | |
| RxCUI: 133063 | Fluprostenol sodium | Designated preferred name (PT) | NO | |
| RxCUI: 133063 | Fluprostenol sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 133064 | Delmadinone acetate | Designated preferred name (PT) | NO | |
| RxCUI: 133064 | Delmadinone acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 133070 | Paroxypropione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 133070 | Paroxypropione | Designated preferred name (PT) | NO | |
| RxCUI: 133070 | Paroxypropione | Full form of descriptor (FN) | NO | |
| RxCUI: 133070 | Paroxypropione | Designated preferred name (PT) | NO | |
| RxCUI: 133070 | Paroxypropione | Full form of descriptor (FN) | NO | |
| RxCUI: 133083 | Alpha-keratin | Designated preferred name (PT) | NO | |
| RxCUI: 133083 | Alpha-keratin | Full form of descriptor (FN) | NO | |
| RxCUI: 133084 | Alpha>2< retinol binding protein | Designated preferred name (PT) | NO | |
| RxCUI: 133084 | Alpha>2< retinol binding protein | Full form of descriptor (FN) | NO | |
| RxCUI: 133086 | Monoclonal cryoglobulin without antibody activity | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133086 | Monoclonal cryoglobulin without antibody activity | Designated preferred name (PT) | NO | |
| RxCUI: 133086 | Monoclonal cryoglobulin without antibody activity | Full form of descriptor (FN) | NO | |
| RxCUI: 133086 | Monoclonal cryoglobulin without antibody activity | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133087 | Mixed cryoglobulin with rheumatoid factor activity | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133087 | Mixed cryoglobulin with rheumatoid factor activity | Designated preferred name (PT) | NO | |
| RxCUI: 133087 | Mixed cryoglobulin with rheumatoid factor activity | Full form of descriptor (FN) | NO | |
| RxCUI: 133087 | Mixed cryoglobulin with rheumatoid factor activity | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133088 | Mixed polyclonal cryoglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133088 | Mixed polyclonal cryoglobulin | Designated preferred name (PT) | NO | |
| RxCUI: 133088 | Mixed polyclonal cryoglobulin | Full form of descriptor (FN) | NO | |
| RxCUI: 133088 | Mixed polyclonal cryoglobulin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133089 | Acid mucopolysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 133089 | Acid mucopolysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 133090 | Beta-lactalbumin | Designated preferred name (PT) | NO | |
| RxCUI: 133090 | Beta-lactalbumin | Full form of descriptor (FN) | NO | |
| RxCUI: 133097 | Macromolecular creatine kinase, type 1 | Designated preferred name (PT) | NO | |
| RxCUI: 133097 | Macromolecular creatine kinase, type 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 133098 | Macromolecular creatine kinase, type 2 | Designated preferred name (PT) | NO | |
| RxCUI: 133098 | Macromolecular creatine kinase, type 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 133099 | Alpha>1< anti-trypsin isotype MM | Designated preferred name (PT) | NO | |
| RxCUI: 133099 | Alpha>1< anti-trypsin isotype MM | Full form of descriptor (FN) | NO | |
| RxCUI: 1331 | Barium sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1331 | Barium sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 1331 | Barium sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 1331 | Barium sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 1331 | Barium sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1331 | Barium sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 133100 | Alpha>1< anti-trypsin isotype MS | Designated preferred name (PT) | NO | |
| RxCUI: 133100 | Alpha>1< anti-trypsin isotype MS | Full form of descriptor (FN) | NO | |
| RxCUI: 133101 | Alpha>1< anti-trypsin isotype MZ | Designated preferred name (PT) | NO | |
| RxCUI: 133101 | Alpha>1< anti-trypsin isotype MZ | Full form of descriptor (FN) | NO | |
| RxCUI: 1331015 | Advanced oxidation protein products | Designated preferred name (PT) | NO | |
| RxCUI: 1331015 | Advanced oxidation protein products | Full form of descriptor (FN) | NO | |
| RxCUI: 133102 | Alpha>1< anti-trypsin isotype SS | Designated preferred name (PT) | NO | |
| RxCUI: 133102 | Alpha>1< anti-trypsin isotype SS | Full form of descriptor (FN) | NO | |
| RxCUI: 133103 | Alpha>1< anti-trypsin isotype SZ | Designated preferred name (PT) | NO | |
| RxCUI: 133103 | Alpha>1< anti-trypsin isotype SZ | Full form of descriptor (FN) | NO | |
| RxCUI: 133104 | Alpha>1< anti-trypsin isotype ZZ | Designated preferred name (PT) | NO | |
| RxCUI: 133104 | Alpha>1< anti-trypsin isotype ZZ | Full form of descriptor (FN) | NO | |
| RxCUI: 133108 | Substance with hormone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 133108 | Substance with hormone receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133108 | Substance with hormone receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133108 | Substance with hormone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 133115 | Ectopic chorionic gonadotrophin secretion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133115 | Ectopic chorionic gonadotrophin secretion | Designated preferred name (PT) | NO | |
| RxCUI: 133115 | Ectopic chorionic gonadotrophin secretion | Full form of descriptor (FN) | NO | |
| RxCUI: 133116 | Aldosterone receptor site | Designated preferred name (PT) | NO | |
| RxCUI: 133116 | Aldosterone receptor site | Full form of descriptor (FN) | NO | |
| RxCUI: 133117 | N^1^-methyl-2-pyridone-5-carboxamide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133117 | N^1^-methyl-2-pyridone-5-carboxamide | Designated preferred name (PT) | NO | |
| RxCUI: 133117 | N^1^-methyl-2-pyridone-5-carboxamide | Full form of descriptor (FN) | NO | |
| RxCUI: 133118 | Antigen of Cryptococcus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133118 | Antigen of Cryptococcus | Full form of descriptor (FN) | NO | |
| RxCUI: 133118 | Antigen of Cryptococcus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133118 | Antigen of Cryptococcus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133118 | Antigen of Cryptococcus | Designated preferred name (PT) | NO | |
| RxCUI: 133119 | Lymphocyte antigen B-B4 | Designated preferred name (PT) | NO | |
| RxCUI: 133119 | Lymphocyte antigen B-B4 | Full form of descriptor (FN) | NO | |
| RxCUI: 133120 | Lymphocyte antigen SMIg kappa | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133120 | Lymphocyte antigen SMIg kappa | Designated preferred name (PT) | NO | |
| RxCUI: 133120 | Lymphocyte antigen SMIg kappa | Full form of descriptor (FN) | NO | |
| RxCUI: 133121 | Lymphocyte antigen SMIg lambda | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133121 | Lymphocyte antigen SMIg lambda | Designated preferred name (PT) | NO | |
| RxCUI: 133121 | Lymphocyte antigen SMIg lambda | Full form of descriptor (FN) | NO | |
| RxCUI: 133122 | Lymphocyte antigen DR | Designated preferred name (PT) | NO | |
| RxCUI: 133122 | Lymphocyte antigen DR | Full form of descriptor (FN) | NO | |
| RxCUI: 133123 | Lymphocyte antigen Cylg | Designated preferred name (PT) | NO | |
| RxCUI: 133123 | Lymphocyte antigen Cylg | Full form of descriptor (FN) | NO | |
| RxCUI: 133123 | Lymphocyte antigen Cylg | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133124 | Lymphocyte antigen Cylg Mu | Designated preferred name (PT) | NO | |
| RxCUI: 133124 | Lymphocyte antigen Cylg Mu | Full form of descriptor (FN) | NO | |
| RxCUI: 133124 | Lymphocyte antigen Cylg Mu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133125 | Lymphocyte antigen GPA | Designated preferred name (PT) | NO | |
| RxCUI: 133125 | Lymphocyte antigen GPA | Full form of descriptor (FN) | NO | |
| RxCUI: 133126 | Lymphocyte antigen MPO | Designated preferred name (PT) | NO | |
| RxCUI: 133126 | Lymphocyte antigen MPO | Full form of descriptor (FN) | NO | |
| RxCUI: 133127 | Salmonella flagellar Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133127 | Salmonella flagellar Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 133127 | Salmonella flagellar Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133127 | Salmonella flagellar Ag | Designated preferred name (PT) | NO | |
| RxCUI: 133127 | Salmonella flagellar Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133128 | Salmonella somatic Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133128 | Salmonella somatic Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 133128 | Salmonella somatic Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133128 | Salmonella somatic Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133128 | Salmonella somatic Ag | Designated preferred name (PT) | NO | |
| RxCUI: 133129 | Lymphocyte antigen CyCD3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133129 | Lymphocyte antigen CyCD3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133133 | Anti-peripheral cell nuclear antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133133 | Anti-peripheral cell nuclear antigen antibody | Designated preferred name (PT) | NO | |
| RxCUI: 133133 | Anti-peripheral cell nuclear antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133133 | Anti-peripheral cell nuclear antigen antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 133134 | Thyroid binding inhibitory immunoglobulins | Designated preferred name (PT) | NO | |
| RxCUI: 133134 | Thyroid binding inhibitory immunoglobulins | Full form of descriptor (FN) | NO | |
| RxCUI: 133135 | Blood group antibody P>2< | Designated preferred name (PT) | NO | |
| RxCUI: 133135 | Blood group antibody P>2< | Full form of descriptor (FN) | NO | |
| RxCUI: 133136 | Acarboxy-coagulation factor VII | Designated preferred name (PT) | NO | |
| RxCUI: 133136 | Acarboxy-coagulation factor VII | Full form of descriptor (FN) | NO | |
| RxCUI: 133137 | Acarboxy-coagulation factor X | Designated preferred name (PT) | NO | |
| RxCUI: 133137 | Acarboxy-coagulation factor X | Full form of descriptor (FN) | NO | |
| RxCUI: 133138 | Tissue plasminogen activator-plasminogen activator inhibitor complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 133138 | Tissue plasminogen activator-plasminogen activator inhibitor complex | Full form of descriptor (FN) | NO | |
| RxCUI: 133138 | Tissue plasminogen activator-plasminogen activator inhibitor complex | Designated preferred name (PT) | NO | |
| RxCUI: 1331688 | Agarum clathratum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1331702 | Solanum dulcamara top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1331704 | Erigeron canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1331704 | Erigeron canadensis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1331705 | Botryoglossum platycarpum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1331706 | Olea europaea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1332038 | Anti-Cytomegalovirus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1332038 | Anti-Cytomegalovirus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1332038 | Anti-Cytomegalovirus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1332038 | Anti-Cytomegalovirus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1332872 | Equisetum hyemale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1332872 | Equisetum hyemale whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1333213 | Iris versicolor root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1333265 | Chelone glabra extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1333267 | Lemna minor extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1333420 | Enterobius vermicularis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1333425 | calcium arsenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1334548 | barium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1334747 | bladderwrack extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1334747 | bladderwrack extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1334747 | bladderwrack extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1334750 | Verbascum thapsus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1334750 | Verbascum thapsus whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1334930 | Mentha piperita whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1334930 | Mentha piperita whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 13356 | 2-enoate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 13356 | 2-enoate reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 1335893 | Curcuma zedoria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336135 | Saccharomyces cerevisiae RNA | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336264 | Chimaphila maculata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336265 | Bryonia dioica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336266 | Lysimachia arvensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336266 | Lysimachia arvensis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1336266 | Lysimachia arvensis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1336267 | Artemisia abrotanum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336269 | Gratiola officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1336269 | Gratiola officinalis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 13369 | octinoxate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1337279 | Gamochaeta purpurea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337279 | Gamochaeta purpurea flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1337618 | walnut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337633 | Euphorbia lathyris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337634 | Lomatium dissectum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337635 | Oxalis montana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337637 | habanero extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1337969 | antimony pentasulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1338620 | Ulva lactuca extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1338933 | sorghum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1338934 | Drosera anglica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1338934 | Drosera anglica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1338937 | Physalis angulata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1338937 | Physalis angulata whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1338938 | pyrrole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1339883 | Collinsonia extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |